Pacanalotamab

Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) targeting to BCMA and CD3ɛ. BCMA refers to B cell maturation antigen, as Pacanalotamab redirecting T cells to BCMA expressing cells on the cell surface. Pacanalotamab conducts T-cell redirected lysis of human multiple myeloma (MM) cell lines.
Read more
€0.00 (tax incl.)
Reference:
HY-P99798
Product Details
HY-P99798

Data sheet

Size
Multiple sizes
Reactivity
CD3
CAS
2251756-52-0

Menu

Settings